Allegra-D 24 Hour FDA Approval History
FDA Approved: Yes (First approved October 19, 2004)
Brand name: Allegra-D 24 Hour
Generic name: fexofenadine and pseudoephedrine
Company: Sanofi Aventis US
Treatment for: Allergic Rhinitis, Nasal Congestion
Allegra-D 24 Hour (fexofenadine and pseudoephedrine) is a once daily prescription antihistamine and decongestant formulation approved for the treatment of seasonal allergy symptoms with nasal congestion in adults and children 12 years of age and older.
Development Timeline for Allegra-D 24 Hour
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.